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ABSTRACT
Objectives Medical futility at the end of life is a growing
challenge to medicine. The goals of the authors were to
elucidate how clinicians define futility, when they
perceive life-sustaining treatment (LST) to be futile, how
they communicate this situation and why LST is
sometimes continued despite being recognised as futile.
Methods The authors reviewed ethics case consultation
protocols and conducted semi-structured interviews with
18 physicians and 11 nurses from adult intensive and
palliative care units at a tertiary hospital in Germany. The
transcripts were subjected to qualitative content
analysis.
Results Futility was identified in the majority of case
consultations. Interviewees associated futility with the
failure to achieve goals of care that offer a benefit to the
patient’s quality of life and are proportionate to the risks,
harms and costs. Prototypic examples mentioned are
situations of irreversible dependence on LST, advanced
metastatic malignancies and extensive brain injury.
Participants agreed that futility should be assessed by
physicians after consultation with the care team.
Intensivists favoured an indirect and stepwise disclosure
of the prognosis. Palliative care clinicians focused on
a candid and empathetic information strategy. The
reasons for continuing futile LST are primarily emotional,
such as guilt, grief, fear of legal consequences and
concerns about the family’s reaction. Other obstacles are
organisational routines, insufficient legal and palliative
knowledge and treatment requests by patients or
families.
Conclusion Managing futility could be improved by
communication training, knowledge transfer,
organisational improvements and emotional and ethical
support systems. The authors propose an algorithm for
end-of-life decision making focusing on goals of
treatment.
INTRODUCTION
If medical treatment is ineffective or unlikely to
achieve an effect that the patient could appreciate
as a benefit, it has been termed futile.1 2 The notion
of medical futility has been heavily criticised on the
grounds that it is ill-defined, blurs medical and
ethical justifications of treatment and contains
negative overtones.2
However, medical futility appears to be a relevant
problem in clinical practice, and a cause of frequent
concern for healthcare professionals, patients, rela-
tives and the law, especially concerning life-
sustaining treatment (LST) at the end of life.3e5
Many hospitals have developed futility policies, and
states have drafted futility laws.6 A growing
concern is how clinicians should react if patients or
family members demand futile treatment, such as
ineffective chemotherapy for end-stage cancer.7
Given the confusion and controversies of the
discourse, it might be helpful to study what clini-
cians themselves think about futility.
Such a study is particularly feasible in a country
like Germany where there is no equivalent term for
medical futility and no associated polemical
battlefield. Instead, German law and ethics focus on
the positive opposite of futility, the so-called
medical indication.8
Our aims were to explore how clinicians them-
selves define medical futility (in German ‘Fehlen
einer medizinischen Indikation’), who they think
should assess this, how they justify performing
futile treatment and how they communicate
futility situations to patients and caregivers.
METHODS
Study design
Because of the explorative nature of our research
aims, and in order to gather in-depth data on the
experiences, attitudes and thoughts of clinicians,
we used a predominantly qualitative mixed-
methods approach, analysing protocols of ethics
consultations and interviews with clinicians. The
study was done in accordance with the require-
ments of the Ethics Committee at our university
hospital.
Document analysis
We analysed 17 ethics consultations at a large
tertiary referral centre in Germany over a 12-month
period. These consultations were sought by clini-
cians who were uncertain whether to administer
LST, offered by ethically trained palliative care
specialists, and conducted in the setting of a team
conference with or without the patient and his
family. They were in accordance with the standards
of clinical ethics consultation as formulated by the
German Academy of Ethics in Medicine.9 For each
consultation, a complete digital result protocol was
accessed, anonymised and analysed using quanti-
tative content analysis.10 The protocols have
a length of 424e1408 words, were written by the
consultants within 2 days after the consultation,
and summarise the clinical situation, the partici-
pants and contents of the discussion, and the
reasons and outcome of decision-making. They
were sent to the care team, included in the patient’s
chart and sometimes given to the patient or family.
Their intention is to document the decision-making
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process in order to guide carers, enhance consistent care across
working shifts and provide legal evidence where needed.
Participant sampling and recruitment
For the interviews, we purposively sampled all physicians and
nurses from intensive care medicine and palliative care medicine
that were present at the ethics consultation meetings (combina-
tion of cluster and stratified sampling). They were considered to
have, presumably, the longest experience with deciding about LST
and futility at the end of life, yet from quite distinct perspectives.
All clinicians could be identified in the consultation protocols and
contacted by email or telephone. They were informed about the
background, aims and procedure of our study, were introduced to
the interviewer ’s professional background, and were guaranteed
voluntary and pseudonymous data processing. All but one of the
physicians we approached agreed to participate. We stopped
sampling when the point of theoretical saturation was reached
and additional interviews did not provide new insights.
Data collection
We conducted semi-structured interviews based on an interview
guide that was developed after the document analysis, and with
the help of pilot testing among experts. It consisted of four
topics: (1) the definition of medical futility, along with typical
examples of futile treatment at the end of life; (2) the persons
who should assess futility; (3) the reasons for providing futile
LST; and (4) the way futility is communicated to patients and
their families. All interviews were conducted by AS, a male final
year medical student pursuing his PhD, experienced in both
intensive and palliative care and skilled in qualitative research
methods. The interviewer was not known to the participants.
The interviews took place in a quiet room in the hospital with
no one else present except for the participant and the inter-
viewer, and lasted 14e52 min. They were audio-recorded
(Olympus WS-300M) and transcribed verbatim, using standard
transcription rules. All transcripts received pseudonyms and
identifiable information was eliminated.
Analysis
We conducted qualitative content analysis according to P
Mayring.11 Transcripts were scrutinised with regard to the
research questions; criteria for defining categories were estab-
lished, and inductive coding was used to generate categories out
of the material. The categories were continuously refined,
ordered and reduced to a higher level of abstraction, using
predefined rules. After 30% of the material had been worked
through, the system of categories was reviewed, and reliability
was tested by a second coder, a senior researcher and physician
skilled in qualitative methods (RJJ). The whole material was
analysed with the help of this category system, and the
frequencies of categories in the material were counted. Finally,
reliability was again tested and quotes were selected for publi-
cation, with the participants’ profession and discipline in
brackets. All interviews were conducted in German, but the
quotes for publication were translated into English by an English
native speaker. Text analysis was aided by the software
MAXqda, V.2 (VERBI GmbH, Marburg, Germany).
RESULTS
Document analysis
Table 1 summarises the information in the 17 consultation
protocols with regard to the patients, the participants of the
discussions, the treatment decisions made and how they relate
to the ethical criteria of patient consent and futility.
Definition of medical futility
We interviewed 29 healthcare professionals, 17 from intensive
care (12 physicians, five nurses) and 12 from palliative care (six
physicians, six nurses). Asked whether they knew of situations
when LSTwas medically futile, 18 participants (62%) responded
affirmatively, 1 (3%) denied it and 10 (34%) were unsure. When
asked to define medical futility at the end of life, interviewees
displayed unease, demonstrated by a longer latency before the
response and an increase of filler words by 17%. The categories
they used for the definition are shown in figure 1.
Most frequently, participants associated futility with the lack
of attainable goals of care:
An intensive care unit is like a bridge which can be used to cross
over a marsh. Having crossed the bridge the path must continue; if
it does not, there is no reason to build the bridge in the first place or
to force the patient onto the bridge (palliative care physician).
Table 1 Analysis of protocols on ethics case consultation (n¼17)
Patients
Median age, in years (range) 69 (19e86)
Surrogates, n 5 spouse, 3 daughter, 2 mother,
1 sister/father/brother
Clinical department, n 5 cardiac surgery, 3 neurosurgery,
3 neurology, 2 anaesthesiology,
2 palliative care, 1 surgery, 1 medicine
Care level, n 10 intensive care unit, 4 intermediate
care unit, 3 others
Participants per consultation meeting
Total number (median), n (range) 6 (4e10)
Consultants (median), n (range) 2 (1e2)
Physicians (median), n (range) 2 (1e4)
Relatives (median), n (range) 2 (0e5)
Nurses (median), n (range) 1 (0e2)
Others (median), n (range) 0.5 (0e1) for example social worker,
chaplain
Treatment decisions* and relation to ethical criteria
Withdraw/withhold LST, n (%) 12 (71)
Because of lack of consent 7 (41)
Because of futility 5 (30)
Continue LST, n (%) 5 (29)
Despite lack of consent 1 (6)
Despite futility 4 (23)
*The ultimate treatment decisions of the healthcare team were not always in line with the
consultants’ recommendations. In the cases where LST was continued despite futility, the
healthcare professionals wanted to give the family more time to cope with the situation
before letting the patient die. In one case, there was family disagreement, and one of the
family members had involved the court.
LST, life-sustaining treatment.
Figure 1 Categories found in the interviews regarding the definition of
medical futility at the end of life. Numbers in brackets show how often
the categories were identified in the interview transcripts. (QoL, quality
of life.)
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Many healthcare professionals also regarded a treatment as
futile if the benefit conferred to the patient by the goal of care
was surmounted by the burden with all associated risks, harms
and expenses:
If I have a patient who has a bronchial carcinoma, and it’s
compressing the large bronchial tubes and causing the patient to be
short of breath, and by ventilation I can only temporise the
decision for 1 or 2 weeks without ever being able to take the patient
off the ventilator, then it’s futile for me (.) Then I have to discuss
with the patient whether the whole expenses and the burden is in
relation to what comes out in the end (palliative care physician).
If the data show that a certain treatment measure will not, with
a reasonable probability, and with reasonable side effects, lead to
the desired goal, then it’s futile (intensive care physician).
Some participants included financial aspects into their benefit-
burden-assessment:
I think it is not sufficient if the treatment doesn’t do any harm. It
also has to help the patient, I think, and, hm, it has to somehow be
responsible within the financial system (palliative care nurse).
Prototypical situations where LST would be futile were
reported to be: (1) an irreversible dependency on LST for the rest
of life; (2) the terminal stage of malignancies; and (3) extreme
injuries like a massive intracerebral haemorrhage.
Participants stated that it is the primary duty of the physician
to assess whether the treatment is medically futile, yet only
after consulting specialists of other medical disciplines (eg,
neurologists) and the nursing team. Some also emphasised that
the patient should be involved in this assessment:
Well, the absolute indication, I think, is quality of life, and this can
only be decided by the patient herself (intensive care nurse).
Reasons for providing futile treatment
Clinicians were asked about the reasons why LST is sometimes
continued despite being considered futile. They came up with
several reasons (figure 2), most notably personal reasons like
concerns, fears and emotions:
The reason is one thing: it’s the fear of both physicians and patients
to talk about death at all (palliative care physician).
Somehow there is a blockade in your head. There is no other reason
for it other than the fear that you could perhaps do something
wrong (intensive care physician).
If, for example, patients come to us from the emergency unit with
wide, fixed pupils and it is not quite clear whether treatment was
really ceased, we still try doing everything. Then they receive
everything, so that we can tell the relatives: ‘we did everything we
could’ (intensive care physician).
Often times it is the doctors that are unable to say: ‘ok, let’s stop’
(.). I don’t know whether that has something to do with their ego
that they think: ‘I do not want to lose him now’ (intensive care
nurse).
Other reasons seem to be treatment wishes of patients or
relatives, ignorance of law and of palliative treatment options,
hope for a miracle, and institutional barriers:
Often there is a surgeon involved who, of course, is still up to
a cure, and for whom it is hard to accept that he cannot go any
further at that point. He has to be heard, and this can take a while
(intensive care physician).
If a patient is declared an emergency patient and comes to the ICU
as such, in principle, he needs treatment, otherwise, there would be
no reason for him to come to our unit (intensive care physician).
We have become so conditioned that we just have to do everything.
And, and, withholding something, or not doing something, we
learnt, means to not help the patient, and this simply contradicts
our medical ethos (intensive care physician).
Communicating futility to families
While nurses and physicians did not differ in their statements,
we found that participants from intensive care and those from
palliative care focus on different aspects when they communi-
cate futility to patients and their families (table 2). Regarding
the setting and form of communication, these differences are
exemplified by the following quotes:
What is paramount is an empathetic conversation. What I always
do at the beginning is to ask what the patient already knows. That
is often different to what is found in the chart or what my opinion
is (palliative care physician).
We usually try to explain to the relatives in several consecutive
conversations, on different days, the difference between prolonging
life and prolonging suffering, so to speak (intensive care physician).
The content of talks about futility also varies somewhat
between the two disciplines. A palliative care physician and an
intensive care nurse describe their approaches in the following
way:
It is very important to be honest with the patient right from the
start. This means saying, for example, with regard to
chemotherapy for a metastatic breast cancer, that it is only about
containing and slowing the tumour growth, not curing it (.). And
you have to tell the patient the alternatives, such as palliative care.
I actually often heard doctors saying “either we do chemotherapy
now or the pain will continue to increase”. I mean, what choice is
then left for the patient? (palliative care physician).
Mostly, it is the case that we nurses and the relatives say “this does
not make sense any more”, the physicians, however, say “yes, yes,
Figure 2 Categories found in the interviews concerning the reasons
given for providing futile treatment at the end of life. Numbers in
brackets show how often the categories were identified in the interview
transcripts.
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we can manage this, he will go to rehab.” Then we just say to the
relatives, rather secretly, “say that your husband would not want
this” (intensive care nurse).
DISCUSSION
Our data confirm the observation that medical futility is a rele-
vant problem at the end of life.12 The majority of ethics case
consultations that we retrospectively analysed (9 of 17)
concerned cases on intensive care units in which the physicians
considered LST to be futile. These situations were so contro-
versial or difficult that they prompted large round-table discus-
sions with the care team, family members and ethics
consultants. Other reviews of ethics consultation confirm the
high prevalence of futility disputes.4 The frequency and societal
relevance of futile treatment at the end of life has just been
underscored by a large retrospective cohort study demonstrating
high rates of surgery in the last weeks and months of life.13
Considering the fact that a large part of lifetime healthcare costs
are caused in the last year of life,14 15 and that reducing non-
beneficial treatment on intensive care units may reduce the
costs,16 this question bears considerable economic and ethical
relevance to society.
Although 9 of the 17 case consultations clarified that LSTwas
futile, this treatment had been provided up until the consulta-
tion meeting in all of these cases, and in four cases futile treat-
ment was continued even after the consultation, mainly in order
to give families more time to cope with the situation. From an
ethical and legal perspective, futile treatment is not justified and
should not be performed.17 However, if we want to improve the
normative practice, we have to study the reasons why futile
treatment is sometimes done, especially at the end of life. In the
interviews with intensive and palliative care clinicians we
identified several possible reasons. Interestingly, demands of
family members was not the most frequently mentioned reason,
in contrast to a survey among Canadian intensivists.3 A plethora
of emotional difficulties surfaced in our interviews, in addition
to well-known problems such as delay due to prognostication
and consensus-seeking, communication problems and lack of
legal or medical knowledge.18 19
Based on these results and the literature, it appears necessary
to improve end-of-life decision making on intensive care units by
various interventions: regular and proactive family meetings,20
effective ethics consultation,16 conducive organisational struc-
tures and applicable hospital policies,6 integration of palliative
care expertise in intensive care,21 improved legal education,
emotional support (eg, by supervision), and specific training of
end-of-life communication skills.22
In our study, the fear of communicating futility to the
patients and their families was mentioned as one of the reasons
for providing futile care. It has been shown that German
physicians tend not to disclose their unilateral decisions about
the futility of treatment at the end of life, especially if they
predict that the patient or family will not agree with this
decision.23 On the other hand, German oncologists justify this
practice by assuming ‘silent acquiescence’ by the patient or the
family.24 It has also been documented that intensive care clini-
cians in Germany are dissatisfied with end-of-life communica-
tion, in particular nurses who run into moral distress when
having to provide futile care despite their moral convictions.19
Of note, in our interviews, we heard that nurses sometimes
team up with the patient’s family and try to get the physicians
to stop LST by supporting the futility judgement with the
assertion of a presumed treatment-opposing will of the
patientdbe it true or not.
It is therefore relevant to know the communication styles
that clinicians favour when disclosing the futility of further
treatment. Our results justify the hypothesis that intensive and
palliative care clinicians follow somewhat different communi-
cation strategies in this respect. While intensive care clinicians
use a more cautious, indirect and matter-of-fact approach,
palliative care clinicians favour a rather swift, direct and
personal approach. Both may have their merits depending on the
circumstances, and it may be necessary to combine elements of
both.25 In order to develop and train the best communicative
approaches, it is imperative to understand more about the needs
of families.26
Last but not least, communication will only succeed if clini-
cians have a proper understanding of the meaning of futility and
its place in decision making. Professional guidelines or hospital
policies on medical futility have been advocated as a means to
improve end-of-life decision making.6 27 In Germany, however,
the few existing professional guidelines on end-of-life decision
making only touch on the issue of futility, and are insufficiently
known by healthcare professionals.28 Hospital policies are still in
a pioneer stage, and the development of such a policy was one of
the lessons our hospital drew from this interview study and
a related survey.19 29
Our data show that clinicians do not share a widely accepted,
readily accessible definition of medical futility. Yet, they identi-
fied key elements of futility that match with the predominant
expert view1 and our own normative analysis. This analysis led
us to a detailed algorithm for end-of-life decision making (see
figure 3). It is not derived from the interview data, but intended
to be a stimulus for normative discussion. The model focuses
primarily on goals of treatment, and secondarily on treatment
measures. It intertwines the two principal ethical grounds of
treatment decisions: patient autonomy and patient wellbeing.
The algorithm visualises that the patient’s autonomous consent
Table 2 Reported practice of communicating futility to patients and their families
Intensive care clinicians Palliative care clinicians
Setting and form Reveal futility stepwise Show empathy
Call other team members to the discussion for support Explore what patient or family
already know or think
Choose the right moment for the discussion*
Give the patient and family time to process the information*
Content Recapitulate illness course so far Be honest about the prognosis
Try to support the futility decision by the patient’s will Offer the treatment alternative
of palliative care
Explain harmful consequences of treatment*
Show unanimity of the professional team*
*Categories found in interviews with both disciplines.
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rests on two critical questions: (1) what is the patient’s preferred
goal of treatment; and (2) how does the patient evaluate the
benefits versus risks and burdens of the intervention needed to
achieve this goal? The responsibility of the clinicians is twofold:
determining the chances to achieve the goal of treatment, and
assessing the likely benefits, risks and burdens according to the
standard of a reasonable person, as a basis for deliberating with
the patient about the intervention. The model thus reflects
a process of shared decision making between the patient, the
family and the clinicians.
In contemplating the chances to reach the goal of treatment
and performing a benefit-burden-analysis, this model covers
both the quantitative and qualitative aspects of medical
futility,2 17 sometimes also called the strict and loose definitions
of futility.30 It clarifies that medical futility may be the result of
a purely factual judgement of prognosis (futility as ineffec-
tiveness). However, it may also be the result of a value judge-
ment that the expected benefit for the patient is outweighed by
the likely negative consequences for the wellbeing of that
particular patient (futility as a negative benefit-burden-ratio).
In the latter sense, it has to include the patient’s view
and, hence, reflects patient autonomy. It is therefore deb-
atable whether ‘futility ’ is a good name for this value judge-
ment that expresses both the physician’s obligations to
beneficence and non-maleficence, and the obligation to respect
patient autonomy.
The model deliberately excludes one further consideration
that is sometimes relevant in treatment decision making, and
has also been addressed by some of our interviewees: the inter-
ests of others, such as the patient’s family or other patients.
Some scholars have advocated that it may be ethically justified
in extreme cases to perform futile treatment for the benefit of
the relatives.31 Moreover, a treatment that is both indicated and
supported by the patient’s will may be legitimately withheld in
a situation of scarce resources and the necessity to do a fair
bedside rationing.7 However, both decisions are based on
grounds of social justice and, hence, considerations of social
ethics apply that may be quite different from that of individual
ethics. Incorporating such considerations into the very concept
of medical futility may obfuscate its meaning and jeopardise
its applicability. Interestingly, neither treatment for the benefit
of third parties, nor bedside rationing, was directly addressed by
the clinicians in our study.
This study has several limitations. Due to the research ques-
tions and the methodology used, it does not purport to yield
a representative picture of clinicians’ perspectives on medical
futility at the end of life, its aim being to generate hypotheses.
The sample was confined to a German hospital and the setting of
intensive care medicine. The descriptive results cannot be used to
support certain normative ethical claims, but they may be of value
for a critical review of the decision-making processes in clinical
practice, and for the planning of future studies on this issue.
In conclusion, this mixed-methods study in the context of
adult intensive and palliative care at a tertiary hospital in
Germany confirms that medical futility is a practically relevant
problem at the end of life, that clinicians have difficulties
defining futility and communicating it to patients or relatives,
and that the major reasons for them to provide futile treatment
at the end of life are their own emotional problems and insti-
tutional barriers.
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